AnalystsSteve Seedhouse
Steve Seedhouse's Stock Forecasts

Analyst Ranking
Top 30%
#1601 out of 5336 analysts
Average Return
+5.58%
Win Rate
50%13 out of 26
Risk vs Reward
Poor
Good

Steve Seedhouse's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Apellis Pharmaceuticals IncAPLS
+129.35%$17.89$41.03
2026-03-18 -
2026-05-15
Strong Buy
Apellis Pharmaceuticals IncAPLS
+92.36%$21.33$41.03
2026-01-13 -
2026-05-15
Strong Buy
Apellis Pharmaceuticals IncAPLS
+78.78%$22.95$41.03
2025-08-01 -
2026-05-15
Strong Buy
Xencor IncXNCR
+68.45%$11.79$19.86
2025-10-06 -
2026-07-27
Strong Buy
Xencor IncXNCR
+41.86%$14.00$19.86
2025-11-06 -
2026-07-27
Strong Buy

Steve Seedhouse Analyst Color

Get additional color on Steve Seedhouse's coverage of popular stocks

Steve Seedhouse's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Eyepoint IncEYPT
1Strong Buy$47.00+278.73%Assumes
20 days ago
Aligos Therapeutics IncALGS
1Strong Buy$20.00+390.20%Initiates Coverage On
2 months ago
Harrow IncHROW
3Strong Buy$88.00+134.92%Maintains
3 months ago
Inflarx NvIFRX
1Strong Buy$4.00+135.29%Maintains
3 months ago
Abcellera Biologics IncABCL
1Strong Buy$7.00+33.33%Initiates Coverage On
3 months ago
Viking Therapeutics IncVKTX
1Strong Buy$100.00+186.78%Maintains
3 months ago
Opus Genetics IncIRD
1Strong Buy$15.00+347.76%Initiates Coverage On
4 months ago
Surrozen IncSRZN
2Strong Buy$40.00+101.92%Reiterates
4 months ago
Apellis Pharmaceuticals IncAPLS
3Strong Buy$31.00-24.45%Maintains
4 months ago
Korro Bio IncKRRO
2Strong Buy$22.00+105.22%Maintains
5 months ago
Belite Bio IncBLTE
2Strong Buy$266.00+67.90%Maintains
5 months ago
Wave Life Sciences LtdWVE
2Strong Buy$41.00+592.57%Maintains
6 months ago
Xencor IncXNCR
2Strong Buy$42.00+111.48%Maintains
9 months ago
Innoviva IncINVA
2Strong Buy$31.00+45.54%Maintains
9 months ago
Camp4 Therapeutics CorpCAMP
1Strong Buy$7.00+104.68%Initiates Coverage On
10 months ago
Tvardi Therapeutics IncTVRD
1Strong Buy$52.00N/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.